Single loading-dose tafenoquine for malaria chemoprophylaxis during brief travel?
作者信息
Baird J Kevin
机构信息
Eijkman-Oxford Clinical Research Unit, Eijkman Institute of Molecular Biology, Jakarta, Indonesia.
Centre for Tropical Medicine and Global Health, Nuffield Department of Medicine, University of Oxford, Oxford, UK.
出版信息
J Travel Med. 2021 Jul 7;28(5). doi: 10.1093/jtm/taab081.
Abstract
摘要
相似文献
1
Single loading-dose tafenoquine for malaria chemoprophylaxis during brief travel?单次负荷剂量他非诺喹用于短期旅行期间的疟疾化学预防？
J Travel Med. 2021 Jul 7;28(5). doi: 10.1093/jtm/taab081.
2
Efficacy of a 3-day pretravel schedule of tafenoquine for malaria chemoprophylaxis: a network meta-analysis.三日前驱期甲氟喹用于疟疾化学预防的疗效：一项网状荟萃分析。
J Travel Med. 2021 Jul 7;28(5). doi: 10.1093/jtm/taab057.
3
Atovaquone-proguanil chemoprophylaxis in the era of Tafenoquine.tafenoquine时代的阿托伐醌-氯胍化学预防
J Travel Med. 2019 Jun 1;26(4). doi: 10.1093/jtm/tay133.
4
Tafenoquine for malaria chemoprophylaxis - Status quo 2022.
Travel Med Infect Dis. 2022 Mar-Apr;46:102268. doi: 10.1016/j.tmaid.2022.102268. Epub 2022 Jan 26.
5
Efficacy and safety of tafenoquine for malaria chemoprophylaxis (1998-2020): A systematic review and meta-analysis.磷酸萘酚喹用于疟疾化学预防的疗效和安全性（1998-2020）：系统评价和荟萃分析。
Travel Med Infect Dis. 2021 Jan-Feb;39:101908. doi: 10.1016/j.tmaid.2020.101908. Epub 2020 Nov 20.
6
Tafenoquine for primary and terminal prophylaxis of malaria in apparently healthy people: a systematic review.特珐瑞喹用于健康人群的疟疾的初级和终末预防：系统评价。
Trans R Soc Trop Med Hyg. 2019 Oct 11;113(10):579-586. doi: 10.1093/trstmh/trz052.
7
Malaria chemoprophylaxis in the age of drug resistance. II. Drugs that may be available in the future.耐药时代的疟疾化学预防。II. 未来可能可用的药物。
Clin Infect Dis. 2001 Aug 1;33(3):381-5. doi: 10.1086/321866. Epub 2001 Jul 5.
8
Malaria chemoprophylaxis with tafenoquine: a randomised study.他非诺喹用于疟疾化学预防：一项随机研究。
Lancet. 2000 Jun 10;355(9220):2041-5. doi: 10.1016/S0140-6736(00)02352-7.
9
Guidance for Using Tafenoquine for Prevention and Antirelapse Therapy for Malaria - United States, 2019.2019 年美国使用他非诺喹预防和抗复发性疟疾的指南。
MMWR Morb Mortal Wkly Rep. 2019 Nov 22;68(46):1062-1068. doi: 10.15585/mmwr.mm6846a4.
10
Blood Schizonticidal Activity and Safety of Tafenoquine When Administered as Chemoprophylaxis to Healthy, Nonimmune Participants Followed by Blood Stage Plasmodium falciparum Challenge: A Randomized, Double-blind, Placebo-controlled Phase 1b Study.替法诺喹作为化学预防用药在健康非免疫人群中的血裂体杀灭活性和安全性，以及随后的血疟原虫感染挑战：一项随机、双盲、安慰剂对照的 1b 期研究。
Clin Infect Dis. 2019 Jul 18;69(3):480-486. doi: 10.1093/cid/ciy939.
引用本文的文献
1
Tafenoquine for the radical cure prophylaxis of malaria: the importance of using the appropriate data set.他非诺喹用于疟疾的根治和预防：使用适当数据集的重要性。
Indian J Med Res. 2023 Aug;158(2):204-210. doi: 10.4103/ijmr.ijmr_405_23.
2
Survey and Analysis of Chemoprophylaxis Policies for Domestic Travel in Malaria-Endemic Countries.疟疾流行国家国内旅行化学预防政策的调查与分析
Trop Med Infect Dis. 2022 Jun 29;7(7):121. doi: 10.3390/tropicalmed7070121.
3
Cost-Benefit Analysis of Tafenoquine for Radical Cure of Malaria in Korea.韩国青蒿琥酯根治疟疾的成本效益分析。
J Korean Med Sci. 2022 Jul 11;37(27):e212. doi: 10.3346/jkms.2022.37.e212.
本文引用的文献
1
Efficacy of a 3-day pretravel schedule of tafenoquine for malaria chemoprophylaxis: a network meta-analysis.三日前驱期甲氟喹用于疟疾化学预防的疗效：一项网状荟萃分析。
J Travel Med. 2021 Jul 7;28(5). doi: 10.1093/jtm/taab057.
2
8-Aminoquinoline Therapy for Latent Malaria.8-氨基喹啉疗法治疗潜伏疟疾。
Clin Microbiol Rev. 2019 Jul 31;32(4). doi: 10.1128/CMR.00011-19. Print 2019 Sep 18.
3
Tafenoquine and G6PD: a primer for clinicians.泰法诺喹与 G6PD：临床医生指南。
J Travel Med. 2019 Jun 1;26(4). doi: 10.1093/jtm/taz023.
4
Hemolytic Potential of Tafenoquine in Female Volunteers Heterozygous for Glucose-6-Phosphate Dehydrogenase (G6PD) Deficiency ( Variant) versus G6PD-Normal Volunteers.他非诺喹对葡萄糖-6-磷酸脱氢酶（G6PD）缺乏（变异型）杂合子女性志愿者与G6PD正常志愿者的溶血潜力。
Am J Trop Med Hyg. 2017 Sep;97(3):702-711. doi: 10.4269/ajtmh.16-0779. Epub 2017 Jul 27.
5
Prophylactic efficacy of primaquine for preventing Plasmodium falciparum and Plasmodium vivax parasitaemia in travelers: A meta-analysis and systematic review.预防用药氯喹预防旅行者感染间日疟原虫和恶性疟原虫的疗效：一项荟萃分析和系统评价。
Travel Med Infect Dis. 2017 May-Jun;17:5-18. doi: 10.1016/j.tmaid.2017.04.005. Epub 2017 Apr 24.
6
Review: Malaria chemoprophylaxis for travelers to Latin America.综述：拉丁美洲旅行者的疟疾化学预防。
Am J Trop Med Hyg. 2011 Dec;85(6):1015-24. doi: 10.4269/ajtmh.2011.11-0464.
7
Randomized, double-blind study of the safety, tolerability, and efficacy of tafenoquine versus mefloquine for malaria prophylaxis in nonimmune subjects.随机、双盲研究了泰法诺喹与甲氟喹预防非免疫人群疟疾的安全性、耐受性和疗效。
Antimicrob Agents Chemother. 2010 Feb;54(2):792-8. doi: 10.1128/AAC.00354-09. Epub 2009 Dec 7.
8
Efficacy of monthly tafenoquine for prophylaxis of Plasmodium vivax and multidrug-resistant P. falciparum malaria.每月服用他非诺喹预防间日疟原虫和耐多药恶性疟原虫疟疾的疗效。
J Infect Dis. 2004 Oct 15;190(8):1456-63. doi: 10.1086/424468. Epub 2004 Sep 20.
9
Primaquine for prevention of malaria in travelers.伯氨喹用于预防旅行者疟疾。
Clin Infect Dis. 2003 Dec 15;37(12):1659-67. doi: 10.1086/379714. Epub 2003 Nov 20.
10
Delayed onset of malaria--implications for chemoprophylaxis in travelers.疟疾的延迟发作——对旅行者化学预防的影响
N Engl J Med. 2003 Oct 16;349(16):1510-6. doi: 10.1056/NEJMoa021592.
Zotero 插件